Loading...
Treatment of early-stage HER2+ breast cancer—an evolving field
The evolving field of HER2-targeted therapy has significantly improved the outcome of women diagnosed with HER2-positive invasive breast cancer. In this review, we sought to summarise the efficacy of trastuzumab-based regimens in the adjuvant and neoadjuvant setting with a special emphasis on releva...
Na minha lista:
| Udgivet i: | Ecancermedicalscience |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cancer Intelligence
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4406526/ https://ncbi.nlm.nih.gov/pubmed/25932047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2015.523 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|